Skip to main content
logo
Scinai Immunotherapeutics Ltd. (TLV:BVXV)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
49.30
-1.00 (-1.99%)
At close: Jan 18, 2018

Scinai Immunotherapeutics Ratios and Metrics

Millions ILS. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jan '18 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
4810936135
Market Cap Growth
-15.76%-24.24%11.37%-74.28%-73.14%29.69%
Enterprise Value
2430115868170

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jan '18 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
0.911.884.34---
PB Ratio
0.120.310.29-0.57-5.8644.21
P/TBV Ratio
0.221.000.66--44.21

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jan '18 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
5.307.224.63---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jan '18 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.310.280.21-4.50-12.2429.52
Net Debt / Equity Ratio
0.080.080.01-3.43-4.2411.82
Net Debt / EBITDA Ratio
-0.14-0.10-0.02-1.71-0.71-1.12
Net Debt / FCF Ratio
-0.12-0.10-0.02-1.57-0.92-1.53
Asset Turnover
0.100.110.04---
Quick Ratio
1.221.151.212.946.077.15
Current Ratio
1.561.301.323.066.157.30
Return on Equity (ROE)
-26.53%-91.89%177.37%---
Return on Assets (ROA)
-36.15%-37.60%-34.92%-27.24%-23.39%-26.97%
Return on Capital Employed (ROCE)
-56.20%-75.10%-74.20%-61.90%-44.70%-36.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jan '18 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-192.09%-336.35%168.09%-250.86%-56.18%-18.90%
FCF Yield
-554.54%-245.17%-222.45%-386.67%-78.52%-17.42%
Buyback Yield / Dilution
-303.74%-189.55%-106.41%-107.22%-33.57%-27.36%